Lord, Abbett & Co’s Hinge Health HNGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.57M Sell
92,547
-607,743
-87% -$25.3M 0.01% 497
2025
Q4
$32.5M Buy
700,290
+51,198
+8% +$2.47M 0.1% 203
2025
Q3
$31.9M Buy
649,092
+133,627
+26% +$6.99M 0.09% 228
2025
Q2
$26.7M Buy
+515,465
New +$20.8M 0.09% 241

Other funds holding HNGE

Lord, Abbett & Co's HNGE Position: Q1 2026 in Review

Lord, Abbett & Co reduced its Hinge Health (HNGE) stake by 87% in Q1 2026, selling an estimated $25.3M and leaving 92,547 shares worth $3.57M. The position accounts for 0.01% of the portfolio, ranked #497.

Lord, Abbett & Co first reported a position in HNGE in Q2 2025 and has held it in 4 quarters since. The position peaked at $32.5M in Q4 2025. 203 funds tracked by Wall St. Rank hold HNGE as of Q1 2026.

  • Lord, Abbett & Co held 92,547 shares of Hinge Health worth $3.57M as of Q1 2026.
  • Lord, Abbett & Co sold 607,743 Hinge Health shares in Q1 2026, an estimated $25.3M.
  • Hinge Health made up 0.01% of Lord, Abbett & Co's portfolio in Q1 2026, its #497 holding.
  • Lord, Abbett & Co first reported a position in Hinge Health in Q2 2025 and has held it in 4 quarters since.
  • Lord, Abbett & Co's Hinge Health position peaked at $32.5M in Q4 2025.
  • 203 funds tracked by Wall St. Rank held Hinge Health as of Q1 2026.

Based on Lord, Abbett & Co's 13F filing for Q1 2026, filed 14 May 2026.